Previous Article | Next Article ![]()
Infection and Immunity, May 1999, p. 2184-2192, Vol. 67, No. 5
Center for Vaccine Development, Department of
Pediatrics, University of Maryland School of Medicine, Baltimore,
Maryland 212011; Department of Public
Health, Faculty of Medicine, UNAM, 04510 Mexico DF,
Mexico2; and Divisions of Infectious
Diseases and Gastroenterology, Johns Hopkins University School of
Medicine, Baltimore, Maryland 212053
Received 20 November 1998/Returned for modification 21 January
1999/Accepted 11 February 1999
We have previously described enteroaggregative Escherichia
coli (EAEC) strains that induce cytotoxic effects on T84 cells, ligated rat ileal loops, and human intestine in culture. Such strains
secrete a 104-kDa protein termed Pet (for plasmid-encoded toxin). We
have also shown previously that the Pet toxin induces rises in
short-circuit current and decreases the electrical resistance in rat
jejunum mounted in an Ussing chamber. The nucleotide sequence of the
pet gene revealed that Pet is a member of the
autotransporter class of secreted proteins. Here we show that a
concentrated supernatant of E. coli HB101 harboring the
minimal pet clone pCEFN1 induces temperature-, time- and
dose-dependent cytopathic effects on HEp-2 cells and HT29
C1 cells in culture. The effects were characterized by
release of the cellular focal contacts from the glass substratum, followed by complete rounding of the cells and detachment from the
glass. Staining of the Pet-treated cells with Live/Dead viability stain
revealed that >90% of rounded cells were viable. Pet-intoxicated HEp-2 and HT29 cells stained with fluorescein-labeled phalloidin revealed contraction of the cytoskeleton and loss of actin stress fibers. However, the effects of Pet were not inhibited by
cytoskeleton-altering drugs, including colchicine, taxol, cytochalasin
D, and phallicidin. The Pet protein induced proteolysis in zymogram
gels, and preincubation with the serine protease inhibitor
phenylmethylsulfonyl fluoride resulted in complete abrogation of Pet
cytopathic effects. We introduced a mutation in a predicted catalytic
serine residue and found that the mutant (Pet S260I) was deficient in
protease activity and did not produce cytopathic effects, cytoskeletal damage, or enterotoxic effects in Ussing chambers. These data suggest
that Pet is a cytoskeleton-altering toxin and that its protease
activity is involved in each of the observed phenotypes.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cytoskeletal Effects Induced by Pet, the Serine
Protease Enterotoxin of Enteroaggregative Escherichia
coli
*
Corresponding author. Mailing address: Department of
Public Health, Faculty of Medicine, UNAM, Ap. Postal 70-443, 04510 Mexico DF, Mexico. Phone: (525) 622-0822. Fax: (525) 622-0827. E-mail: fnavarro{at}servidor.unam.mx.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|